124 related articles for article (PubMed ID: 7856104)
1. Activation of the interferon-inducible enzymes, 2',5'-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element.
Mordechai E; Kon N; Henderson EE; Suhadolnik RJ
Virology; 1995 Feb; 206(2):913-22. PubMed ID: 7856104
[TBL] [Abstract][Full Text] [Related]
2. Activation of interferon-inducible 2'-5' oligoadenylate synthetase by adenoviral VAI RNA.
Desai SY; Patel RC; Sen GC; Malhotra P; Ghadge GD; Thimmapaya B
J Biol Chem; 1995 Feb; 270(7):3454-61. PubMed ID: 7531709
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
[TBL] [Abstract][Full Text] [Related]
4. Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1.
Sharp TV; Raine DA; Gewert DR; Joshi B; Jagus R; Clemens MJ
Virology; 1999 May; 257(2):303-13. PubMed ID: 10329541
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of human (2'-5')oligoadenylate synthetase gene expression by the phorbol ester 12-O-tetradecanoyl-phorbol 13-acetate in type-I-interferon-treated HL-60 and HeLa cells.
Chang CC; Borelli TJ; Williams BR; Wu JM
Eur J Biochem; 1992 Jul; 207(1):297-304. PubMed ID: 1628655
[TBL] [Abstract][Full Text] [Related]
6. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
[TBL] [Abstract][Full Text] [Related]
8. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'-5') oligoadenylate synthetase and PKR.
Salzberg S; Mandelboim M; Zalcberg M; Shainberg A
Exp Cell Res; 1995 Jul; 219(1):223-32. PubMed ID: 7628537
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
[TBL] [Abstract][Full Text] [Related]
10. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
Ho AD; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
Leukemia; 1992 Mar; 6(3):209-14. PubMed ID: 1564958
[TBL] [Abstract][Full Text] [Related]
11. Enzymology of interferon action. The (2'-5')(A)n synthetase-RNase L pathway.
Dougherty JP; Samanta H; Floyd-Smith G; Broeze R; Jayaram BM; Lengyel P
Tex Rep Biol Med; 1981-1982; 41():443-51. PubMed ID: 6189208
[No Abstract] [Full Text] [Related]
12. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase.
Li SW; Moskow JJ; Suhadolnik RJ
J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823
[TBL] [Abstract][Full Text] [Related]
13. Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.
Li M; Zheng DJ; Field LL; Bonnevie-Nielsen V
Exp Diabetes Res; 2009; 2009():631026. PubMed ID: 19888425
[TBL] [Abstract][Full Text] [Related]
14. Impairment of intracellular antiviral defense with age: age-dependent changes in expression of interferon-induced and double-stranded RNA-activated 2-5A synthetase in rat.
Kuusksalu A; Truve E; Aaspollu A; Kelve M; Scheffer U; Müller WE; Schröder HC
Mech Ageing Dev; 1995 Mar; 78(2):103-15. PubMed ID: 7541098
[TBL] [Abstract][Full Text] [Related]
15. Functional differences in the promoters of the interferon-inducible (2'-5')A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells.
Guille MJ; Laxton CD; Rutherford MN; Williams BR; Kerr IM
Eur J Biochem; 1994 Jan; 219(1-2):547-53. PubMed ID: 8307020
[TBL] [Abstract][Full Text] [Related]
16. [Demonstration of an interferon alpha receptor in human colonic cancer cells in culture].
Boissard C; Chelbi Alix MK; Gali P; Thang MN; Rosselin G
C R Acad Sci III; 1989; 309(11):485-92. PubMed ID: 2533880
[TBL] [Abstract][Full Text] [Related]
17. Role of 2'-5'-oligoadenylate synthetase in gamma-interferon-mediated growth inhibition of A431 cells.
Kumar R; Mendelsohn J
Cancer Res; 1989 Sep; 49(18):5180-4. PubMed ID: 2504485
[TBL] [Abstract][Full Text] [Related]
18. Specific regulation of the 100 kDa 2-5 A synthetase by protein kinase C.
Raber J; Eldar H; Lehrer R; Chebath J; Livneh E
Eur Cytokine Netw; 1991; 2(4):281-90. PubMed ID: 1756233
[TBL] [Abstract][Full Text] [Related]
19. [Influence of chemically different antiviral substances on the expression of IFNα, PKR, OAS1a and RNAse L genes].
Drahushchenko OO; Minia IĬ; Poliezhaeva TA; Starosyla DB; Karpova IS; Obolens'ka MIu; Rybalko SL
Ukr Biokhim Zh (1999); 2012; 84(4):32-40. PubMed ID: 22946298
[TBL] [Abstract][Full Text] [Related]
20. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
Díaz-Guerra M; Rivas C; Esteban M
Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
